JOP20230169A1 - علاج انقطاع النفس أثناء النوم باستخدام cbd - Google Patents

علاج انقطاع النفس أثناء النوم باستخدام cbd

Info

Publication number
JOP20230169A1
JOP20230169A1 JOJO/P/2023/0169A JOP20230169A JOP20230169A1 JO P20230169 A1 JOP20230169 A1 JO P20230169A1 JO P20230169 A JOP20230169 A JO P20230169A JO P20230169 A1 JOP20230169 A1 JO P20230169A1
Authority
JO
Jordan
Prior art keywords
cbd
treating sleep
sleep apnea
treating
cannabidiol
Prior art date
Application number
JOJO/P/2023/0169A
Other languages
Arabic (ar)
English (en)
Inventor
Donna Gutterman
Joseph Palumbo
Terri Sebree
Original Assignee
Harmony Biosciences Man Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harmony Biosciences Man Inc filed Critical Harmony Biosciences Man Inc
Publication of JOP20230169A1 publication Critical patent/JOP20230169A1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Glass Compositions (AREA)
JOJO/P/2023/0169A 2021-01-28 2023-07-27 علاج انقطاع النفس أثناء النوم باستخدام cbd JOP20230169A1 (ar)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163142835P 2021-01-28 2021-01-28
PCT/IB2022/050781 WO2022162621A1 (en) 2021-01-28 2022-01-28 Treatment of sleep apnea with cbd

Publications (1)

Publication Number Publication Date
JOP20230169A1 true JOP20230169A1 (ar) 2023-07-27

Family

ID=80222209

Family Applications (1)

Application Number Title Priority Date Filing Date
JOJO/P/2023/0169A JOP20230169A1 (ar) 2021-01-28 2023-07-27 علاج انقطاع النفس أثناء النوم باستخدام cbd

Country Status (11)

Country Link
US (1) US20240307418A1 (cg-RX-API-DMAC7.html)
EP (1) EP4284349A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024505212A (cg-RX-API-DMAC7.html)
KR (1) KR20230137404A (cg-RX-API-DMAC7.html)
CN (1) CN116829135A (cg-RX-API-DMAC7.html)
AU (1) AU2022213009A1 (cg-RX-API-DMAC7.html)
CA (1) CA3206508A1 (cg-RX-API-DMAC7.html)
IL (1) IL304827A (cg-RX-API-DMAC7.html)
JO (1) JOP20230169A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023008876A (cg-RX-API-DMAC7.html)
WO (1) WO2022162621A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20260207632A1 (en) * 2022-12-16 2026-07-23 Kingdom Therapeutics Limited Cannabinoid based therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8449908B2 (en) 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
WO2010127033A1 (en) 2009-04-28 2010-11-04 Alltranz Inc. Formulations of cannabidiol and methods of using the same
CA3065563C (en) * 2017-06-19 2023-06-13 Zelda Therapeutics Operations Pty Ltd Sleep disorder compositions and treatments thereof
GB2572737A (en) * 2018-01-24 2019-10-16 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
CA3099980A1 (en) * 2018-05-11 2019-11-14 Rhodes Technologies Inc. Compositions and dosage forms for oral delivery
WO2019224824A1 (en) * 2018-05-24 2019-11-28 To Pharmaceuticals Llc Cannabis-based compositions for the treatment of autistic spectrum disorders
EP3753555A1 (en) * 2019-06-19 2020-12-23 Universität Basel Composition for inhalation comprising cannabidiol for the treatment of mental disorder and/or drug addiction and/or sleep disorder and/or pain
WO2021055499A1 (en) * 2019-09-17 2021-03-25 Zynerba Pharmaceuticals, Inc. Treatment of behavioral impairment in developmental and epileptic encephalopathy

Also Published As

Publication number Publication date
CN116829135A (zh) 2023-09-29
US20240307418A1 (en) 2024-09-19
IL304827A (en) 2023-09-01
MX2023008876A (es) 2023-09-12
WO2022162621A1 (en) 2022-08-04
JP2024505212A (ja) 2024-02-05
AU2022213009A1 (en) 2023-08-17
EP4284349A1 (en) 2023-12-06
KR20230137404A (ko) 2023-10-04
CA3206508A1 (en) 2022-08-04

Similar Documents

Publication Publication Date Title
JOP20210140A1 (ar) معالجة متلازمة الحذف 22q11.2 بكانابيديول
JOP20200082A1 (ar) علاج متلازمة الكروموسوم إكس الهش باستخدام الكانابيديول
JOP20200031A1 (ar) طرق لعلاج الالتهاب العظمي المفصلي باستخدام هلام من كانابيديول عبر الأدمة
MX380767B (es) Métodos para reducir el riesgo cardiovascular.
EA201201465A1 (ru) Лекарственные формы хинонов для лечения офтальмических заболеваний
EA201690754A1 (ru) Применение ингибитора pcsk9 для лечения гиперлипидемии
BR112013027554A2 (pt) "usos de compostos no tratamento de mal de alzheimer, doença de huntington, autismo e outros distúrbios"
UY35313A (es) Antiadhesion de leucocitos para mitigar los potenciales eventos adversos causados por los dominios de unión específicos de cd3
EA201590849A1 (ru) Композиции, способы и применения для лечения диабета и связанных состояний посредством контроля уровня глюкозы крови
BR112015027282A2 (pt) fenfluramina para uso no tratamento de síndrome de dravet
BR112015022197A2 (pt) tratamento de cataplexia
AR097178A1 (es) Diagnóstico y terapias anticáncer que comprenden células madre cancerosas
EA201591687A1 (ru) Индукционная терапия ритуксимабом с последующим лечением с использованием глатирамера ацетата
BR112014007357A2 (pt) métodos de monitoramento terapêutico de fármacos de varredura de nitrogênio
BR112014031806A8 (pt) método para tratamento de câncer positivo para gd2
NZ716627A (en) Methods of treating behavioral symptoms of neurological and mental disorders
MX2022003193A (es) Tratamiento de encefalopatia asociada al gen syngap1.
EA201590654A1 (ru) Комбинация разагилина и придопидина для лечения нейродегенеративных нарушений, в частности болезни хантингтона
BR112015026238A2 (pt) tratamento de câncer com dihidropirazino-pirazinas
BR112016012840A2 (pt) Derivado de pirimidina e fonte de ácido graxo para uso no tratamento de prisão de ventre
EA202091446A1 (ru) Способы лечения хронических воспалительных заболеваний
MY196979A (en) Method of treating disease by auricular anesthesia of cranial nerves
MX2023008876A (es) Tratamiento de la apnea del sueño con cannabidiol (cbd).
BR112020012668A8 (pt) Composição para o tratamento de um paciente com doença respiratória associada a inflamações crônicas e método de produção e utilização da composição
BR112015007095A2 (pt) derivados de di-hidro-6-azafenaleno para o tratamento de doenças do snc, oncológicas e distúrbios relacionados